The FDA published more than 200 complete response letters, the first step in what it describes as part of its effort to modernize the agency and improve transparency. But there are some caveats to the release of the FDA correspondence. The post Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits appeared first…
Tia Health recently launched its longevity service line, which is starting with a focus on heart health. It includes labs and one-on-one provider guidance. The post Women’s Health Company Tia Health Launches Longevity Service Line appeared first on MedCity News.
The promise of current and future technologies is encouraging – and it further underscores the importance of building the right support systems to help patients navigate the system and access the appropriate care at the right time and place. The post Better Navigation is Key to Improving Behavioral Health Access and Outcomes appeared first on…
Improving the outlook starts with a better supply chain model — one that shifts from a transactional to strategic focus and is built on collaborative supplier models and more domestic sourcing. The post Healthcare’s Tariff Conundrum: Mitigating Supply Chain Risks with Data and Relationships appeared first on MedCity News.
This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care. The post GLP-1s, Personalization, and Big Pharma Power Plays: What’s Really at Stake in the Eli Lilly Lawsuit appeared first on MedCity News.
A bipartisan group of lawmakers introduced legislation this week to extend CMS’ hospital-at-home waiver for five more years, allowing hospitals to continue delivering acute care in patients’ homes with Medicare reimbursement. The move comes as research shows this model reduces mortality and healthcare costs. The post New Legislation Seeks to Preserve Hospital-at-Home Reimbursement Until 2030…
Capricor Therapeutics said the FDA asked for more data supporting the efficacy of Deramiocel, the biotech’s off-the-shelf cell therapy for treating the heart complications of Duchenne muscular dystrophy. Those data could come from an ongoing Phase 3 study expected to yield preliminary data soon. The post FDA Turns Down Capricor Cell Therapy for Cardio Complications…
We can’t ignore what AI makes possible: faster diagnoses, smarter workflows, better use of limited resources, and more personalized care at scale. If we get this right, we can build a system that works better for everyone, not just the few who can afford concierge care or live near major medical centers. The post AI…
As AI tools continue to evolve, they promise to empower clinicians and administrators with actionable insights, improve patient outcomes, and create more resilient healthcare systems. The post Upholding “Do No Harm” in the Age of AI appeared first on MedCity News.
The right technology infrastructure enables organizations to link their teams and achieve better care outcomes while improving operational efficiency and developing lasting resilience. The post Closing the Gap Between Patient Care and Operations with Smarter, Scalable Tech appeared first on MedCity News.